Brand Spin-offs: When Companies Sell Off Their Own Brands

The Age of the Corporate Spin-off

Johnson & Johnson's consumer health division generated $15 billion in annual revenue and J&J spun it off anyway. That decision — which created Kenvue as an independent NYSE-listed company in May 2023 — is the clearest example of a structural shift in how major corporations think about brand ownership.

For most of the twentieth century, the dominant strategy was consolidation. Buy more brands. Enter more categories. Build a bigger empire. That logic produced Procter & Gamble's 80+ brand portfolio, Unilever's 400-brand footprint, and General Electric's sprawling industrial-and-consumer conglomerate.

Now the biggest corporations are running that logic in reverse. Kellogg split into two companies. GE divided into three. Pfizer's consumer health division became Haleon. These are not distressed sales. They are healthy companies concluding that their brands are worth more apart than together — and the M&A data supports them.

We tracked every major brand spin-off from 2022 through 2026 to explain why this is happening and what it means for the products on your shelf.

Why Companies Spin Off Brands

1. Unlock Hidden Value

When a high-growth division is bundled with slower-growing businesses inside a conglomerate, investors apply a "conglomerate discount" to the combined entity. Spinning off the faster-growing unit lets the market price it independently, often at a higher multiple.

J&J's consumer health division generated approximately $15 billion in annual revenue, but pharmaceutical investors did not value it at consumer sector multiples. By separating Kenvue as an independent company in May 2023, J&J allowed healthcare investors to own the pharmaceutical business without the consumer business weighing on the multiple, and vice versa. Kenvue's IPO raised $3.8 billion — the largest U.S. IPO of 2023.

2. Strategic Focus

Managing consumer brands like Tylenol and Band-Aid requires fundamentally different skills, supply chains, and marketing strategies than developing pharmaceutical drugs. By separating, each company can focus entirely on its core competency.

As J&J CEO Joaquin Duato explained at the time of the Kenvue separation, the consumer health business "will be best positioned to deliver long-term growth as a standalone company."

3. Activist Investor Pressure

Activist investors are the accelerant. Nelson Peltz's Trian Fund Management has pressured multiple consumer goods companies — P&G, Unilever, Kraft Heinz — to simplify their portfolios. Elliott Management has pushed for changes at conglomerates including Honeywell and 3M. The playbook is consistent: identify a conglomerate with a high-value division being obscured by lower-margin businesses, build a stake, and demand a separation.

4. Tax Efficiency

In the United States, tax-free spin-offs under Section 355 of the Internal Revenue Code allow corporations to separate businesses without triggering capital gains taxes for the parent company or its shareholders. This tax advantage makes spin-offs economically attractive compared to outright sales.

5. Capital Allocation

Different businesses have different capital needs. A pharmaceutical company investing billions in drug R&D has different priorities than a consumer brands company investing in marketing and distribution. Separation allows each entity to allocate capital optimally.

The Biggest Brand Spin-offs of 2023-2026

Johnson & Johnson to Kenvue (2023)

What separated: J&J's entire consumer health division New company: Kenvue (NYSE: KVUE) Key brands: Tylenol, Listerine, Neutrogena, Aveeno, Band-Aid, Johnson's Baby, Zyrtec Annual revenue: approximately $15 billion IPO: May 2023, raised $3.8 billion — largest U.S. IPO of 2023

Kenvue is the world's largest pure-play consumer health company. J&J retained pharmaceuticals and medical devices. The separation is permanent: J&J divested its remaining Kenvue stake through 2024.

Kellogg to Kellanova and WK Kellogg Co (2023)

What separated: Kellogg's snacking division from its North American cereal division New companies: Kellanova (NYSE: K) for snacks; WK Kellogg Co (NYSE: KLG) for cereals Key Kellanova brands: Pringles, Cheez-It, Pop-Tarts, Eggo, Rice Krispies Treats Key WK Kellogg brands: Frosted Flakes, Froot Loops, Raisin Bran

Kellanova was acquired by Mars, Incorporated for $35.9 billion in early 2025. That outcome validated the spin-off strategy directly: a clean, focused snacking company attracted a premium-price acquisition that would not have been possible with the cereal business attached.

Pfizer/GSK to Haleon (2022)

What separated: Pfizer and GSK's consumer health joint venture New company: Haleon (LSE: HLN) Key brands: Sensodyne, Advil, Centrum, Theraflu, Robitussin, Emergen-C Annual revenue: ~$12 billion

Haleon combined Pfizer's consumer health brands (Advil, Centrum, Theraflu) with GSK's (Sensodyne, Voltaren) into the world's largest standalone consumer health company alongside Kenvue.

General Electric Three-Way Split (2023-2024)

What separated: GE's aviation, healthcare, and energy businesses New companies: GE Aerospace, GE HealthCare, GE Vernova Logic: Each business operates in fundamentally different markets with different capital needs, regulatory environments, and customer bases.

Unilever Ice Cream Separation (2025)

What separated: Unilever's entire ice cream division New company: Independent ice cream company (in process) Key brands: Ben & Jerry's, Magnum, Wall's, Breyers, Talenti Annual revenue: ~$8 billion

Unilever announced in 2024 that it would separate its ice cream business into a standalone company, a move partly driven by the operational differences between ice cream (cold chain logistics) and Unilever's other consumer goods. The separation was completed in 2025.

The Spin-off Pattern

Examining recent spin-offs reveals a consistent pattern:

What Changes for Consumers After a Spin-off

• Almost nothing changes from a consumer perspective
• Products remain the same formulation
• Distribution and availability unchanged
• Packaging may gradually update with new corporate branding

• New company may invest differently in different brands
• Innovation priorities may shift based on the new company's strategy
• Marketing budgets may increase or decrease for specific brands
• The new company may make its own acquisitions or divestitures

• Brand portfolio may look significantly different as the new company pursues its own strategy
• The new company could itself be acquired (as happened with Kellanova/Mars)
• Product quality could improve or decline based on new ownership priorities

Spin-offs vs. Sales: What Is the Difference?

Sometimes both happen in sequence: Kellogg spun off Kellanova (spin-off), and then Mars acquired Kellanova (sale). The spin-off created a cleaner, more valuable target for acquisition.

Brands Most Likely to Be Spun Off Next

Based on industry analysis and investor pressure, these divisions are candidates for future spin-offs:

• Consumer health divisions of pharmaceutical companies that have not yet separated
• Food and beverage divisions of diversified conglomerates
• Legacy media assets within technology-focused parent companies
• Beauty and personal care divisions of companies refocusing on other categories

Frequently Asked Questions

What is a corporate spin-off?

A spin-off is when a parent company separates a division or brand portfolio into a new, independent publicly traded company. Existing shareholders of the parent company typically receive shares in the new company proportional to their existing holdings.

Do spin-offs affect product quality?

In the short term, product quality typically remains unchanged. The same employees, formulations, and manufacturing processes continue. Over the longer term, the new company's investment priorities and strategic direction may affect product quality positively or negatively.

Why are spin-offs happening more frequently?

Spin-offs have increased because investors increasingly value focused companies over conglomerates, activist investors push for portfolio simplification, and management teams recognize that different businesses thrive with different strategies and capital allocation priorities.

Can a spun-off company be acquired?

Yes. Kellanova was spun off from Kellogg in October 2023 and acquired by Mars for $36 billion in December 2025, demonstrating that spin-offs can create acquisition targets.

The Bottom Line

Spin-offs are not a reversal of consolidation. They are a correction. Companies that accumulated too many disparate businesses under one roof are now separating them so each can attract the right investors, the right management team, and the right capital allocation strategy.

For consumers, the short-term impact is minimal. The Tylenol you buy from Kenvue is the same product it was under J&J. Pringles under Mars is the same chip it was under Kellogg. The ownership changes are real. The product on the shelf usually is not.

Track brand ownership changes on WhoBrands or explore the full list of companies and their portfolios.

Explore Related Brands

• Tylenol - Pain reliever, spun off from J&J into Kenvue
• Neutrogena - Skincare, now part of Kenvue
• Listerine - Mouthwash, now part of Kenvue
• Cheez-It - Crackers, spun off then acquired by Mars
• Pop-Tarts - Toaster pastries, spun off then acquired by Mars
• Aveeno - Skincare, now part of Kenvue

Browse all brands

Sources

1. Johnson & Johnson. "Kenvue Separation." Press releases, 2023. jnj.com 2. Kellogg Company. "Separation into Kellanova and WK Kellogg Co." 2023. 3. Mars, Incorporated. "Kellanova Acquisition." Press release, 2025. 4. Haleon. "Formation and IPO." haleon.com/investors 5. Unilever. "Ice Cream Division Separation." Press release, 2024-2025. 6. SEC Filings. Form 10-K and 8-K for Kenvue (KVUE), Haleon (HLN).

All brand ownership data verified through WhoBrands.com's research methodology. Last updated: February 3, 2026.